Phase I safety, pharmacokinetics, and inhibition of src activity study of saracatinib in patients with solid tumors

  1. Baselga, J.
  2. Cervantes, A.
  3. Martinelli, E.
  4. Chirivella, I.
  5. Hoekman, K.
  6. Hurwitz, H.I.
  7. Jodrell, D.I.
  8. Hamberg, P.
  9. Casado, E.
  10. Elvin, P.
  11. Swaisland, A.
  12. Iacona, R.
  13. Tabernero, J.
Aldizkaria:
Clinical Cancer Research

ISSN: 1078-0432,  1557-3265

Argitalpen urtea: 2010

Alea: 16

Zenbakia: 19

Orrialdeak: 4876-4883

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-10-0748 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus